Preferences
Related Series
Related Segments


Gravimetric Verification In IV Workflow Management 2021
How Has The Market Progressed?
Current Time Inside Cache Tag Helper: 6/10/2023 6:09:12 AM and Model.reportId = 1788
Gravimetric verification has been touted as a way to drive significant patient safety gains, and most major IV workflow management vendors have released this functionality. However, the associated challenges (e.g., maintaining an accurate drug density database, changes to compounding workflows) have hurt perceived value for some healthcare organizations, and so far, only BD has demonstrated broad deployment in their customer base. This report examines the maturity of vendors’ gravimetric verification functionality, provides a first look at BD’s performance in this area, and assesses how the technology affects purchase decisions across the market.if you don't have a login, getting started is easy.
Key Findings:
- BD Far Outpaces Competitors in Rolling Out Gravimetric Verification to Customers
- BD Seen as Pioneer with Gravimetric Verification Adoption Push; Customers Need More Help Navigating the Learning Curve
- Grifols’ Stable Technology and Responsive Support Drive Satisfaction
- Buying Energy: Lack of Gravimetric Verification Proof Points Limits Baxter, Epic, Grifols & Omnicell

Writer
Amanda Wind Smith

Designer
Jess Wallace-Simpson

Project Manager
Isaac Burgi
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.